Poland · PL-100441528
Aboxoma
A apixaban product containing apixabanum, registered in Poland by Krka, d.d., Novo mesto d.o.o.. The same ATC class is registered in 15 of our countries.
Checked against URPL (Poland) on
Where it is registered
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Countries holding a registration under ATC B01AF02. Markets marked price are the ones where we can also compare cost per daily dose — open the comparison with a free account.
At a glance
- Active substance
- Apixabanum
- Manufacturer
- Krka, d.d., Novo mesto d.o.o.
- Country
- Poland (PL)
- ATC code
- B01AF02
- ATC class
- Apixaban
- Defined daily dose
- 10 mg, O
- Dispensing
- —
- Reimbursed
- No
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin03838989738341
- gtin03838989738365
- gtin03838989738389
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class, other countries
Other records under ATC B01AF02 — apixaban.
- AbatixentPoland · Sandoz GmbH
- AbatixentPoland · Sandoz GmbH
- Abatixent 2,5 mg filmomhulde tablettenNetherlands · Sandoz B.V.
- Abatixent 5 mg filmomhulde tablettenNetherlands · Sandoz B.V.
- AbidaloGermany · 123 Acurae Pharma Gmbh
- AboxomaPoland · Krka, d.d., Novo mesto d.o.o.
- ABOXOMACzechia · Krka, d.d., Novo mesto, Novo mesto
- ABOXOMACzechia · Krka, d.d., Novo mesto, Novo mesto
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/318f5fd6-dca4-4e34-acb5-6824c604a282 GET /v1/drugs/318f5fd6-dca4-4e34-acb5-6824c604a282?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "2,5 mg",
"packaging": "03838989738341 ¦ Rp ¦ 148604\n20 tabl.\n03838989738365 ¦ Rp ¦ 148605\n56 tabl.\n03838989738389 ¦ Rp ¦ 148606\n60 tabl.",
"substance": "Apixabanum 2.5 mg",
"common_name": "Apixabanum",
"pl_product_id": "100441528",
"pozwolenie_nr": "27618",
"auth_procedure": "DCP",
"authorisation_validity": "2028-01-17"
}Keep going
See everything about apixabanum
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction checking is on the Growth plan. No card, nothing to install.